InvestorsHub Logo
Followers 2
Posts 2022
Boards Moderated 0
Alias Born 05/11/2017

Re: None

Friday, 12/27/2019 9:53:49 AM

Friday, December 27, 2019 9:53:49 AM

Post# of 108192
The next news from the company was supposed to be a start of Ph2 HPV+ lung cancer study by a Taiwan partner (2H2019), but the time has almost run out. So, guessing no news, no trial started. Maybe, the partner got cold feet.

Another "news" could be a termination of PSA trial and shelving the program. Merck, the potential partner for PSA program, has had lots of time to look under the hood and made no decision to jump in. Why? The only reasonable explanation is the data was not that impressive. ADXS cannot continue to pay for that trial, let alone take it to Phase 3. As the other trials before (Aim2Cerv, NEO, and etc), this PSA program is destined to wither and disappear from their corporate presentations. I'll give it a month or so. Then, the whole focus is going to be on HOT. Very binary outcome...
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent ADXS News